Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning.
My colleague recently had a chance to talk with former senator Ben Sasse about his experience taking Revolution Medicines’ pancreatic cancer pill. Read on for what he said.
Ben Sasse thinks Rev Med drug ‘extended both quality and quantity of life’ Yesterday, we got highly promising results from a trial of Revolution Medicines’ pancreatic cancer pill, showing that patients on the medication lived nearly twice as long as those on chemotherapy. Continue to STAT+ to read the full story...
STAT News published a clinical update in Research Highlights on 14 Apr 2026.
The item focuses on STAT+: FDA pressures drugmakers to report trial results.
Review the original article for the full source wording and details.